Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Disease Outbreaks | 11 | 2021 | 124 | 2.580 |
Why?
|
Mumps | 5 | 2021 | 18 | 1.920 |
Why?
|
Immunization Programs | 3 | 2016 | 28 | 1.130 |
Why?
|
Arkansas | 20 | 2022 | 2094 | 1.120 |
Why?
|
Mumps virus | 3 | 2021 | 19 | 1.060 |
Why?
|
Histoplasmosis | 3 | 2018 | 53 | 1.020 |
Why?
|
Mycobacterium Infections, Nontuberculous | 1 | 2020 | 19 | 0.760 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2019 | 5 | 0.690 |
Why?
|
School Health Services | 2 | 2016 | 52 | 0.650 |
Why?
|
Lyme Disease | 1 | 2017 | 28 | 0.620 |
Why?
|
Clinical Laboratory Techniques | 1 | 2017 | 31 | 0.620 |
Why?
|
Vaccination | 2 | 2019 | 293 | 0.620 |
Why?
|
Sepsis | 1 | 2020 | 251 | 0.610 |
Why?
|
Absenteeism | 1 | 2016 | 18 | 0.560 |
Why?
|
Smallpox | 1 | 2015 | 3 | 0.540 |
Why?
|
Smallpox Vaccine | 1 | 2015 | 2 | 0.540 |
Why?
|
Immunity, Humoral | 1 | 2015 | 25 | 0.530 |
Why?
|
Bambusa | 1 | 2014 | 2 | 0.490 |
Why?
|
Pertussis Vaccine | 1 | 2013 | 2 | 0.480 |
Why?
|
Fires | 1 | 2014 | 19 | 0.480 |
Why?
|
Whooping Cough | 1 | 2013 | 15 | 0.470 |
Why?
|
Communicable Disease Control | 1 | 2013 | 39 | 0.460 |
Why?
|
Endemic Diseases | 2 | 2018 | 29 | 0.460 |
Why?
|
Medical Informatics Applications | 1 | 2013 | 6 | 0.460 |
Why?
|
Mandatory Reporting | 1 | 2013 | 13 | 0.450 |
Why?
|
Coccidioidomycosis | 1 | 2012 | 7 | 0.420 |
Why?
|
Blastomycosis | 1 | 2012 | 61 | 0.410 |
Why?
|
Cooperative Behavior | 1 | 2013 | 254 | 0.410 |
Why?
|
Internet | 1 | 2013 | 275 | 0.370 |
Why?
|
Neoplasms | 1 | 2020 | 1315 | 0.370 |
Why?
|
Humans | 31 | 2022 | 54246 | 0.350 |
Why?
|
Incidence | 4 | 2019 | 1082 | 0.310 |
Why?
|
Population Surveillance | 2 | 2018 | 183 | 0.270 |
Why?
|
Influenza, Human | 2 | 2016 | 120 | 0.250 |
Why?
|
Male | 15 | 2019 | 27312 | 0.230 |
Why?
|
Child, Preschool | 6 | 2021 | 4146 | 0.230 |
Why?
|
Adolescent | 7 | 2021 | 6885 | 0.220 |
Why?
|
Fishes | 2 | 2001 | 26 | 0.210 |
Why?
|
Hot Springs | 1 | 2022 | 2 | 0.210 |
Why?
|
Legionella pneumophila | 1 | 2022 | 6 | 0.210 |
Why?
|
Legionnaires' Disease | 1 | 2022 | 4 | 0.210 |
Why?
|
Methotrexate | 1 | 2022 | 73 | 0.210 |
Why?
|
Pfiesteria piscicida | 1 | 2001 | 2 | 0.210 |
Why?
|
Adult | 11 | 2021 | 14182 | 0.210 |
Why?
|
Female | 13 | 2019 | 28418 | 0.210 |
Why?
|
Water Supply | 2 | 2022 | 21 | 0.200 |
Why?
|
Nontuberculous Mycobacteria | 1 | 2020 | 9 | 0.190 |
Why?
|
Aged, 80 and over | 6 | 2019 | 3429 | 0.190 |
Why?
|
Genotype | 2 | 2019 | 599 | 0.190 |
Why?
|
Middle Aged | 9 | 2021 | 13070 | 0.190 |
Why?
|
Environmental Exposure | 2 | 2001 | 205 | 0.190 |
Why?
|
Outpatients | 1 | 2020 | 123 | 0.180 |
Why?
|
Child | 6 | 2021 | 7337 | 0.180 |
Why?
|
Serologic Tests | 1 | 2019 | 28 | 0.170 |
Why?
|
Antibodies, Viral | 2 | 2019 | 124 | 0.170 |
Why?
|
Burkholderia Infections | 1 | 2018 | 6 | 0.170 |
Why?
|
Burkholderia | 1 | 2018 | 16 | 0.170 |
Why?
|
Chagas Disease | 1 | 2018 | 4 | 0.170 |
Why?
|
Wound Infection | 1 | 2018 | 31 | 0.170 |
Why?
|
Young Adult | 5 | 2021 | 4308 | 0.160 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2019 | 206 | 0.160 |
Why?
|
Histoplasma | 1 | 2018 | 29 | 0.160 |
Why?
|
Infant | 4 | 2021 | 3817 | 0.160 |
Why?
|
Emigrants and Immigrants | 1 | 2018 | 38 | 0.160 |
Why?
|
Genome, Bacterial | 1 | 2018 | 141 | 0.150 |
Why?
|
Babesiosis | 1 | 2017 | 7 | 0.150 |
Why?
|
Public Health | 2 | 2019 | 206 | 0.150 |
Why?
|
Water Wells | 1 | 2016 | 1 | 0.140 |
Why?
|
Droughts | 1 | 2016 | 7 | 0.140 |
Why?
|
Ticks | 1 | 2016 | 6 | 0.140 |
Why?
|
Tick-Borne Diseases | 1 | 2016 | 4 | 0.140 |
Why?
|
Ownership | 1 | 2016 | 21 | 0.140 |
Why?
|
Transients and Migrants | 1 | 2016 | 26 | 0.140 |
Why?
|
Cause of Death | 1 | 1997 | 165 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2017 | 138 | 0.140 |
Why?
|
Cryptococcosis | 1 | 2015 | 21 | 0.140 |
Why?
|
Cryptococcus neoformans | 1 | 2015 | 28 | 0.130 |
Why?
|
Tuberculosis | 1 | 2016 | 104 | 0.130 |
Why?
|
Medical Staff, Hospital | 1 | 2015 | 19 | 0.130 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2015 | 23 | 0.130 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 80 | 0.130 |
Why?
|
Influenza Vaccines | 1 | 2015 | 42 | 0.130 |
Why?
|
Nursing Staff, Hospital | 1 | 2015 | 48 | 0.130 |
Why?
|
Regression Analysis | 1 | 2016 | 445 | 0.130 |
Why?
|
Mycobacterium tuberculosis | 1 | 2016 | 212 | 0.130 |
Why?
|
Aged | 6 | 2019 | 10041 | 0.130 |
Why?
|
Salmonella Food Poisoning | 1 | 2014 | 5 | 0.120 |
Why?
|
Salmonella | 1 | 2014 | 25 | 0.120 |
Why?
|
Hepatitis C, Chronic | 1 | 2015 | 89 | 0.120 |
Why?
|
School Nursing | 1 | 2013 | 13 | 0.120 |
Why?
|
Prisons | 1 | 2014 | 35 | 0.120 |
Why?
|
Prostatic Neoplasms | 1 | 1997 | 415 | 0.110 |
Why?
|
Health Personnel | 1 | 2015 | 246 | 0.110 |
Why?
|
United States | 6 | 2022 | 5200 | 0.100 |
Why?
|
Genome, Viral | 2 | 2021 | 100 | 0.090 |
Why?
|
Water Microbiology | 2 | 2022 | 25 | 0.090 |
Why?
|
Phylogeny | 2 | 2019 | 269 | 0.080 |
Why?
|
Hip Fractures | 1 | 2008 | 53 | 0.080 |
Why?
|
Diarrhea | 2 | 2014 | 90 | 0.080 |
Why?
|
Treatment Outcome | 1 | 2019 | 5604 | 0.080 |
Why?
|
Chickenpox Vaccine | 1 | 2006 | 5 | 0.070 |
Why?
|
Chickenpox | 1 | 2006 | 15 | 0.070 |
Why?
|
Social Support | 1 | 2008 | 298 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2014 | 1228 | 0.060 |
Why?
|
Neuropsychological Tests | 2 | 2001 | 363 | 0.050 |
Why?
|
Inhalation Exposure | 1 | 2001 | 34 | 0.050 |
Why?
|
Pharyngitis | 1 | 2001 | 17 | 0.050 |
Why?
|
Nausea | 1 | 2001 | 52 | 0.050 |
Why?
|
Washington | 1 | 2021 | 46 | 0.050 |
Why?
|
Eye Diseases | 1 | 2001 | 35 | 0.050 |
Why?
|
Headache | 1 | 2001 | 78 | 0.050 |
Why?
|
Water | 1 | 2022 | 102 | 0.050 |
Why?
|
Aerosols | 1 | 2001 | 76 | 0.050 |
Why?
|
Mortality | 1 | 2001 | 102 | 0.050 |
Why?
|
Abdominal Pain | 1 | 2001 | 77 | 0.050 |
Why?
|
Micronesia | 1 | 2021 | 116 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 1679 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 216 | 0.050 |
Why?
|
Biopsy | 1 | 2022 | 692 | 0.050 |
Why?
|
Mumps Vaccine | 1 | 2019 | 9 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2019 | 33 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2018 | 2907 | 0.040 |
Why?
|
Antibodies, Neutralizing | 1 | 2019 | 75 | 0.040 |
Why?
|
Animals | 4 | 2016 | 14385 | 0.040 |
Why?
|
Multilocus Sequence Typing | 1 | 2018 | 19 | 0.040 |
Why?
|
Bacterial Typing Techniques | 1 | 2018 | 32 | 0.040 |
Why?
|
Trypanosoma cruzi | 1 | 2018 | 3 | 0.040 |
Why?
|
Latin America | 1 | 2018 | 11 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2018 | 15 | 0.040 |
Why?
|
Amnesia | 1 | 1998 | 9 | 0.040 |
Why?
|
Dinoflagellida | 1 | 1998 | 5 | 0.040 |
Why?
|
Fish Diseases | 1 | 1998 | 5 | 0.040 |
Why?
|
Geography, Medical | 1 | 2018 | 5 | 0.040 |
Why?
|
Public Health Surveillance | 1 | 2018 | 13 | 0.040 |
Why?
|
History, 21st Century | 1 | 2018 | 62 | 0.040 |
Why?
|
Babesia | 1 | 2017 | 6 | 0.040 |
Why?
|
Quinine | 1 | 2017 | 7 | 0.040 |
Why?
|
Clindamycin | 1 | 2017 | 15 | 0.040 |
Why?
|
Wisconsin | 1 | 1997 | 43 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2017 | 32 | 0.040 |
Why?
|
Doxycycline | 1 | 2017 | 46 | 0.040 |
Why?
|
Cohort Studies | 2 | 2015 | 1543 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2017 | 225 | 0.040 |
Why?
|
Water Quality | 1 | 2016 | 7 | 0.040 |
Why?
|
Communicable Diseases, Emerging | 1 | 2016 | 14 | 0.040 |
Why?
|
Bird Diseases | 1 | 2015 | 2 | 0.030 |
Why?
|
Liver | 1 | 2022 | 1225 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2016 | 249 | 0.030 |
Why?
|
Birds | 1 | 2015 | 13 | 0.030 |
Why?
|
Hospitals, Community | 1 | 2015 | 21 | 0.030 |
Why?
|
Uridine Monophosphate | 1 | 2015 | 3 | 0.030 |
Why?
|
Risk Factors | 3 | 2015 | 3930 | 0.030 |
Why?
|
Ribavirin | 1 | 2015 | 16 | 0.030 |
Why?
|
Hepatitis C Antibodies | 1 | 2015 | 21 | 0.030 |
Why?
|
Focus Groups | 1 | 2016 | 208 | 0.030 |
Why?
|
Drug Costs | 1 | 2015 | 35 | 0.030 |
Why?
|
Serotyping | 1 | 2014 | 15 | 0.030 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 28 | 0.030 |
Why?
|
Food Contamination | 1 | 2014 | 42 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2015 | 231 | 0.030 |
Why?
|
Food Handling | 1 | 2014 | 37 | 0.030 |
Why?
|
Antiviral Agents | 1 | 2015 | 188 | 0.030 |
Why?
|
Hospitalization | 1 | 2018 | 705 | 0.030 |
Why?
|
Feces | 1 | 2014 | 135 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 1048 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2015 | 6432 | 0.020 |
Why?
|
Baltimore | 1 | 2008 | 31 | 0.020 |
Why?
|
Friends | 1 | 2008 | 21 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 431 | 0.020 |
Why?
|
Family | 1 | 2008 | 191 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2008 | 643 | 0.020 |
Why?
|
Survival Rate | 1 | 2008 | 951 | 0.020 |
Why?
|
Schools | 1 | 2006 | 176 | 0.020 |
Why?
|
Prospective Studies | 1 | 2008 | 2604 | 0.010 |
Why?
|
Maryland | 1 | 1998 | 34 | 0.010 |
Why?
|
Hotlines | 1 | 1998 | 16 | 0.010 |
Why?
|